Cervical cancer remains a devastating reality for countless Malian women. Fatoumata, a 38-year-old mother, is one of its many victims.

« I initially had a fibroid, and it took me time to treat it. It was only when I started bleeding that I had surgery. After the operation, I began experiencing watery, odorless discharge. I consulted my gynecologist, and the results revealed cervical cancer. My treatment cost between 5 and 6 million West African CFA francs, with the surgery alone amounting to 2 million francs. »

This initiative aims to protect over 320,000 young girls annually, potentially reducing cervical cancer cases by nearly 90% and preventing more than 3,600 deaths among Malian women each year.

Fatoumata’s story highlights the challenges faced by women with late diagnoses and the financial burden of treatment in Mali, where access to quality healthcare remains limited.

the heavy burden of cervical cancer in Mali

Cervical cancer, caused by persistent infection with certain types of HPV, is a major public health issue in Mali. It is the second most common cancer among women aged 15 to 44 in the country. Often detected too late, this disease continues to claim thousands of lives annually.

Cultural taboos further complicate the situation, preventing women from openly discussing their symptoms. Superstitions sometimes associate the disease with curses or spells, delaying diagnosis and worsening outcomes. « Cervical cancer is sometimes perceived as a curse cast by a co-wife, sister-in-law, or former partner, » explains a reproductive health advocate.

a historic breakthrough: HPV vaccine introduction

In a landmark decision, the Malian government has recently included the HPV vaccine in its routine immunization schedule. Dr. Ibrahima Diarra, Director of the National Immunization Center, emphasized the importance of this advancement during the Bamako launch event: « A single dose can protect a 10-year-old girl for over a decade against the viruses responsible for 70% of cervical cancers. » The vaccine is now free for young girls, supported by Gavi and co-financed by the Malian state.

This initiative aims to protect over 320,000 girls annually, potentially reducing cervical cancer cases by nearly 90% and preventing more than 3,600 deaths among Malian women each year.

further reading

• human papillomavirus (HPV): a vaccineswork guide
• three malawian girls share their dreams instead of worrying about cervical cancer

a step toward health equity

This vaccination program marks a significant stride toward health equity. Cervical cancer claims the lives of thousands of women daily, particularly in low-income countries. In 2022, 348,000 global deaths were recorded, 90% in these countries. By introducing the vaccine, Mali takes a just step toward making prevention accessible to all girls, whether in urban or rural areas.

Dr. Diarra explains the choice of targeting 10-year-old girls: « We selected this age group because their cervix is still healthy, before the onset of sexual activity, ensuring maximum vaccine efficacy. » This approach aligns with the World Health Organization’s (WHO) recommendation to prioritize vaccination for girls aged 9 to 14.

Mali stands out as one of the first Sahelian nations—and the first Gavi-supported fragile and conflict-affected country—to introduce the HPV vaccine.

By preventing cervical cancer, the introduction of the HPV vaccine also reduces the financial burden of costly treatments. « A single dose costs around 150,000 FCFA in private pharmacies, but thanks to Gavi’s support and Malian state co-financing, the vaccine is now free under the routine immunization program, » Dr. Diarra notes with satisfaction.

Mali’s groundbreaking initiative not only safeguards generations of Malian women but also serves as a model for other countries in the region. This achievement aligns with Gavi’s global goals to vaccinate 86 million girls in low- and middle-income countries by 2025.

combating misinformation

Malian health authorities face a critical challenge: misinformation. Rumors and fake news sometimes circulate about vaccines, fueled by opponents. « It’s crucial to counter this misinformation. This vaccine is safe, effective, and does not compromise the fertility or reproductive health of young girls, » insists Dr. Diarra.

Health Minister Colonel Assa Badiallo Touré also reaffirmed the vaccine’s safety and importance during the launch.

The introduction of the HPV vaccine represents a significant victory for women’s health and a step toward a more equitable future in Mali. By breaking the cycle of disease through prevention, the country sets an example of a people-centered public health model that protects the most vulnerable and ensures a safer future for Malian women.